Bill Haddad - Spark Newswire

1 minute read

Pixelworks Announces Its Pixelworks Semiconductor Technology subsidiary Entered Agreement With Investors; Employee Entities To Pay $1.4M In Exchange For 0.54% Equity Interest

Today, 6:30 PM

PORTLAND, Ore., Dec. 28, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW) (the "Company"), a leading provider of innovative video and display processing solutions, today announced the Company'sPORTLAND, Ore., Dec. 28, 2022 /PRNewswire/ -- Pixelworks, Inc.

PXLW

1 minute read

Sempra Infrastructure Enters Long-Term Sale And Purchase Agreement With RWE Supply & Trading For Supply Of 2.25M Tonnes er Annum Of LNG

By Bill Haddad

Today, 6:30 PM

HOUSTON, Dec. 28, 2022 /PRNewswire/ -- Sempra Infrastructure, a subsidiary of Sempra (NYSE:SRE) (BMV:SRE), today announced it has entered into a long-term sale and purchase agreement (SPA) with

BMV:SRE

1 minute read

Legal
News

‘California Bans Tesla From Marketing Its EVs As ‘Full Self-Driving” -Inside EVs

By Bill Haddad

Today, 6:30 PM

https://insideevs.com/news/628539/california-bans-tesla-from-marketing-its-evs-as-full-self-driving/

TSLA

1 minute read

News

AppHarvest Completes Sale-Leaseback Deal With Mastronardi Berea LLC

By Bill Haddad

Today, 6:30 PM

MOREHEAD, Ky., Dec. 27, 2022 (GLOBE NEWSWIRE) -- AppHarvest, Inc. (NASDAQ:APPH, APPHW)))), a sustainable food company, public benefit corporation and Certified B Corp building some of the world's largest high-tech

APPH

1 minute read

News

Amyris Completes Negotiation And Financial And Business Terms Of Transaction

By Bill Haddad

Today, 6:30 PM

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform today announced that it has

AMRS

2 minute read

Catalyst Biosciences And GNI Group Sign Agreements Fro Sale And Purchase Of F351 Program; Announces $7.5M Special Divided And Contingent Value Right

By Bill Haddad

Today, 6:30 PM

Acquires F351, a Phase 3 Drug to Treat Fibrosis Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in Subsequent Transaction Announces $7.5

CBIO

1 minute read

Gold Royalty Corp. FY22 Total Revenue And Option Proceeds From Royalty Generation Program $5.7M

By Bill Haddad

Today, 6:30 PM

Total Revenue and Option Proceeds1 from the royalty generation program, of $0.9 million and $5.7 million for the three months and year ended September 30, 2022, respectively,

GROY

1 minute read

First Light Acquisition Group Inc. Says On December 21, 2022, Bill Weber Resigned From His Position As Co-Chief Executive Officer; As Of Dec 22, 2022, Thomas A. Vecchiolla Will Serve As Sole Chief Executive Officer And Chairman Of Board

By Bill Haddad

Today, 6:30 PM

-Reuters

FLAG

1 minute read

Purple Innovation Inc Files For Mixed Shelf Of Up To $90M

By Bill Haddad

Today, 6:30 PM

-SEC Filing

PRPL

1 minute read

BrainStorm Cell Therapeutics Announces Type A Meeting With FDA Granted For NurOwn; Meeting Scheduled For Jan. 11, 2023

By Bill Haddad

Today, 6:30 PM

NEW YORK, Dec. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S.

BCLI